Fierce Pharma
JULY 3, 2024
After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week. | After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week.
MedCity News
JULY 3, 2024
Abbott recently launched the FreeStyle Libre 3 Plus sensor, which it says is the smallest and most discreet sensor on the market. It will soon be available in U.S. retail pharmacies and medical equipment suppliers. The post Abbott Says Its Latest CGM Sensor Is Its Most Discreet Yet appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 3, 2024
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID-19 jabs.
MedCity News
JULY 3, 2024
The Rise Fund will lead a $200 million investment in Foodsmart. The funding will help the telenutrition company scale its business. The post Foodsmart Snags $200M Investment Led By TPG’s Rise Fund appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
JULY 3, 2024
Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from Eisai/Biogen.
MedCity News
JULY 3, 2024
GSK is taking over development of an avian influenza vaccine candidate as a bird flu outbreak continues in U.S. dairy cows. Meanwhile, CureVac is restructuring and returning its attention to cancer vaccines, which was the initial focus of the mRNA company. The post GSK Pays CureVac €400M to Pick Up Clinical-Stage mRNA Vaccines for Infectious Diseases appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 3, 2024
Finding a payment technology solution that is specifically designed for alternative payment models like capitation helps payers and providers achieve financial sustainability in a value-based system. The post Capitation Technology Drives Financial Viability in Value-Based Care Models appeared first on MedCity News.
pharmaphorum
JULY 3, 2024
EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies
MedCity News
JULY 3, 2024
Data exchange lies at the heart of innovation. With the right data available, BioPharma companies can best implement advanced analytics tools for timely interventions in manufacturing deficiencies and optimize processes. The post Ensuring Data Integrity in BioPharmaceutical Manufacturing: The Need for Contextualization and Cloud-based Integration appeared first on MedCity News.
PharmaTimes
JULY 3, 2024
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JULY 3, 2024
Academic institutions and nonprofit organisations are jumping in to save access to complex gene therapies.
PharmaTimes
JULY 3, 2024
Chronic migraine is a neurological condition estimated to affect up to 2.
PharmaVoice
JULY 3, 2024
GeoVax is developing a next-gen COVID vaccine targeting a population that’s so far been elusive: immunocompromised patients.
pharmaphorum
JULY 3, 2024
J&J’s multiple myeloma CAR-T Carvykti improves survival when used as a second-line or later therapy, raising the pressure on BMS’ rival Abecma
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
JULY 3, 2024
The EMA has granted approval to Sanofi's Dupixent for adults with uncontrolled chronic obstructive pulmonary disease (COPD).
PharmaTech
JULY 3, 2024
Kisunla (donanemab-azbt) reduced amyloid plaques in Phase III study participants by 84% after 18 months.
Pharmaceutical Technology
JULY 3, 2024
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).
PharmaTech
JULY 3, 2024
A greater number of patients with Duchenne muscular dystrophy will be able to be treated after FDA's approval of a gene therapy.
Pharmaceutical Technology
JULY 3, 2024
Beacon’s lead candidate AGTC-501 is currently in a Phase II/III clinical trial for the treatment of X-linked retinitis pigmentosa (XLRP).
Clarivate
JULY 3, 2024
The medical technology industry is emerging from a turbulent pandemic era strong, with some really exciting innovations making their way to patients, several of which we showcased in our recent Medical Technologies to Watch report. However, to realize the promise of these and other innovations, MedTech companies must navigate a fast-changing clinical, competitive and regulatory environment that presents a complex web of challenges.
Pharmaceutical Commerce
JULY 3, 2024
The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.
PharmExec
JULY 3, 2024
Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage development and licensure of a pre-pandemic vaccine targeting the H5 influenza virus.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PM360
JULY 3, 2024
Former Publicis Chief Digital Officer joins Klick to take its growing Media team into the future Klick Health today announced that healthcare media veteran Ray Rosti has been named President, Klick Media. The agency’s Chief Operating Officer Greg Rice said that Rosti’s proven innovative approach and deep understanding of digital strategies made him the perfect candidate for the new role as Klick continues to expand and enhance its media capabilities. “We are thrilled to welcome Ray as Pres
Pharmaceutical Technology
JULY 3, 2024
Emergent will supply vaccines for anthrax and smallpox, VIV for treating smallpox vaccine complications, and a botulism antitoxin.
Pharmaceutical Commerce
JULY 3, 2024
The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product.
Pharmaceutical Technology
JULY 3, 2024
The takeover, which includes the candidate felzartamab, for immune-mediated diseases, diversifies Biogen’s scope.
Evolve Your Success
JULY 3, 2024
Join us for an insightful conversation with Vendela Martin, a trailblazing medical sales rep and LinkedIn content creator who transitioned from B2B sales at ADP to an impactful role in medical device sales, specializing in minimally invasive surgery for GYN surgeons. Vendela shares her journey and the pivotal moments that validated her career change, offering a glimpse into the importance of her product and the collaborative dynamics of her team.
Pharmaceutical Commerce
JULY 3, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
PharmExec
JULY 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JULY 3, 2024
Metal contamination in pharmaceutical products is a huge problem. Detection and removal of these contaminants is critical during milling.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
302 
Let's personalize your content